TortsProf Blog

Editor: Christopher J. Robinette
Widener Commonwealth Law School

Monday, October 1, 2018

Abilify Mass Tort Suit: Alleged Danger of Compulsive Sex and Gambling

Abilify, a drug used to treat schizophrenia and bipolar disorder, is the subject of a mass tort suit claiming it leads to destructive behaviors.  The drug was brought into the U.S. market by Otsuka America and Bristol-Myers Squibb in 2002.  Prior to any warnings in the U.S., European and Canadian warning labels stated that Abilify could unleash "destructive behaviors."  On May 3, 2016, the FDA required an addition to Abilify's labels warning of  “compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex.”  Complaints allege failure to warn and failure to adequately test the drug.  The Daily Beast has the story.

https://lawprofessors.typepad.com/tortsprof/2018/10/abilify-mass-tort-suit-alleged-danger-of-compulsive-sex-and-gambling.html

Products Liability | Permalink

Comments

Post a comment